[go: up one dir, main page]

MXPA02006617A - Dihidrobenzopiranos, dihidrobenzotiopiranos, y tetrahidroquinolinas para el tratamiento de desordenes mediados por cox-2. - Google Patents

Dihidrobenzopiranos, dihidrobenzotiopiranos, y tetrahidroquinolinas para el tratamiento de desordenes mediados por cox-2.

Info

Publication number
MXPA02006617A
MXPA02006617A MXPA02006617A MXPA02006617A MXPA02006617A MX PA02006617 A MXPA02006617 A MX PA02006617A MX PA02006617 A MXPA02006617 A MX PA02006617A MX PA02006617 A MXPA02006617 A MX PA02006617A MX PA02006617 A MXPA02006617 A MX PA02006617A
Authority
MX
Mexico
Prior art keywords
dihydrobenzothiopyrans
dihydrobenzopyrans
tetrahydroquinolines
disorders
treatment
Prior art date
Application number
MXPA02006617A
Other languages
English (en)
Inventor
Donald J Rogier Jr
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22635573&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA02006617(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of MXPA02006617A publication Critical patent/MXPA02006617A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Quinoline Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se describe una clase de dihidrobenzopiranos, dihidrobenzotiopiranos, tetrahidroquinolinas, tetrahidronaftalenos, y analogos de los mismos, para el uso en el tratamiento de desordenes mediados por la ciclooxigenasa-2. Los compuestos de interes particular son definidos por la formula (I) en donde X, A1, A2, A3, A4, R , R????, R1 y R2 son como se describen en la especificacion.
MXPA02006617A 2000-01-03 2000-12-19 Dihidrobenzopiranos, dihidrobenzotiopiranos, y tetrahidroquinolinas para el tratamiento de desordenes mediados por cox-2. MXPA02006617A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17428100P 2000-01-03 2000-01-03
PCT/US2000/034525 WO2001049675A1 (en) 2000-01-03 2000-12-19 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders

Publications (1)

Publication Number Publication Date
MXPA02006617A true MXPA02006617A (es) 2004-09-10

Family

ID=22635573

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02006617A MXPA02006617A (es) 2000-01-03 2000-12-19 Dihidrobenzopiranos, dihidrobenzotiopiranos, y tetrahidroquinolinas para el tratamiento de desordenes mediados por cox-2.

Country Status (16)

Country Link
US (2) US6822102B2 (es)
EP (1) EP1274700B1 (es)
JP (1) JP2003519221A (es)
AR (1) AR026784A1 (es)
AT (1) ATE282604T1 (es)
AU (1) AU2584001A (es)
CA (1) CA2395795A1 (es)
DE (1) DE60016047T2 (es)
EC (1) ECSP013867A (es)
ES (1) ES2231301T3 (es)
MX (1) MXPA02006617A (es)
PE (1) PE20010995A1 (es)
PT (1) PT1274700E (es)
TW (1) TWI227234B (es)
WO (1) WO2001049675A1 (es)
ZA (1) ZA200205098B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100594A1 (en) * 2001-08-10 2003-05-29 Pharmacia Corporation Carbonic anhydrase inhibitor
US7211672B2 (en) 2002-10-04 2007-05-01 Millennium Pharmaceuticals, Inc. PGD2 receptor antagonists for the treatment of inflammatory diseases
US7504508B2 (en) 2002-10-04 2009-03-17 Millennium Pharmaceuticals, Inc. PGD2 receptor antagonists for the treatment of inflammatory diseases
US7299448B2 (en) 2003-03-28 2007-11-20 International Business Machines Corporation Context-sensitive attributes
GB0407908D0 (en) * 2004-04-07 2004-05-12 Univ York Ionic liquids
TW200603792A (en) * 2004-04-23 2006-02-01 Pharmacia & Upjohn Co Llc Monotherapy for the treatment of psoriasis with cyclooxygenase-2 selective inhibitors
US7122700B2 (en) 2004-07-30 2006-10-17 Xerox Corporation Arylamine processes
WO2006040672A1 (en) * 2004-10-12 2006-04-20 Pharmacia & Upjohn Company Llc Substituted cyclopropyl chromene compounds for use in the treatment and prevention of inflammation related conditions
WO2006091674A1 (en) 2005-02-24 2006-08-31 Millennium Pharmaceuticals, Inc. Pgd2 receptor antagonists for the treatment of inflammatory diseases
US7999107B2 (en) 2007-01-31 2011-08-16 Merck Sharp & Dohme Corp. Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators
EA022046B1 (ru) 2010-07-14 2015-10-30 Новартис Аг Гетероциклические соединения, агонисты рецептора ip
AR089698A1 (es) 2012-01-13 2014-09-10 Novartis Ag Compuestos heterociclicos antagonistas del receptor ip
CN119954759B (zh) * 2025-01-03 2025-10-21 安炎达医药技术(广州)有限公司 一种苯并吡喃类cox-2抑制剂及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2262671A1 (en) * 1996-08-27 1998-03-05 Shionogi & Co., Ltd. Chromene-3-carboxylate derivatives
DE19638484A1 (de) * 1996-09-20 1998-03-26 Basf Ag Hetaroylderivate
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation
US6077850A (en) * 1997-04-21 2000-06-20 G.D. Searle & Co. Substituted benzopyran analogs for the treatment of inflammation

Also Published As

Publication number Publication date
WO2001049675A1 (en) 2001-07-12
ES2231301T3 (es) 2005-05-16
CA2395795A1 (en) 2001-07-12
DE60016047T2 (de) 2005-11-03
US20050010050A1 (en) 2005-01-13
AR026784A1 (es) 2003-02-26
ZA200205098B (en) 2004-03-31
TWI227234B (en) 2005-02-01
AU2584001A (en) 2001-07-16
ECSP013867A (es) 2002-09-27
JP2003519221A (ja) 2003-06-17
US20030232844A1 (en) 2003-12-18
PE20010995A1 (es) 2001-09-21
PT1274700E (pt) 2005-02-28
ATE282604T1 (de) 2004-12-15
US6822102B2 (en) 2004-11-23
EP1274700B1 (en) 2004-11-17
EP1274700A1 (en) 2003-01-15
DE60016047D1 (de) 2004-12-23

Similar Documents

Publication Publication Date Title
BG105513A (en) Substituted benzopyran analogs for the treatment of inflammation
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
NZ514234A (en) N-cyanomethylamides as protease inhibitors
MXPA02006617A (es) Dihidrobenzopiranos, dihidrobenzotiopiranos, y tetrahidroquinolinas para el tratamiento de desordenes mediados por cox-2.
YU5503A (sh) Nesteroidni supresori zapaljenja
MXPA04001889A (es) Inhibidores de la alquin-aril fosfodiesterasa-4.
WO2002032874A3 (en) Substituted heterocyclic compounds for treating multidrug resistance
DE60220422D1 (de) Substituierte pyrazoloverbindungen zur behandlung von entzündungen
WO2002008194A8 (de) Acridin-derivate und deren verwendung als arzneimittel
AU2002224927A1 (en) Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds
NZ521681A (en) Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
AU2002213421A1 (en) Condensed pyridoindole derivatives
MXPA02012076A (es) Compuestos quimicos.
AU2001266575A1 (en) Chemical compounds
MXPA03009750A (es) Compuestos quimicos.
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
CA2474510A1 (en) Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
WO2002010152A3 (de) Neue indolderivate und deren verwendung als arzneimittel
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
AU2002213419A1 (en) Condensed pyridoindole derivatives
BR0012751A (pt) Benzofuranos serotonérgicos
MXPA06003345A (es) Derivados de aminopiridina como inhibidores de la no-sintasa inducible.
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
AU2001296699A1 (en) Condensed pyrazindione derivatives as pde inhibitors